Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors


Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., ...Daha Fazla

TUMORI, cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 89 Sayı: 2
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1177/030089160308900207
  • Dergi Adı: TUMORI
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.141-145
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Aims and background: We evaluated the efficacy and tolerability of weekly irinotecan as a second-line treatment in patients with colorectal cancer failing 5-fluorouracil-based chemotherapy and searched for predictive and prognostic factors.